Baixar PDF
Voltar à página
If you have problems to see the content please click here
Outros usuários também visualizaram estes artigos
Epidemiological characterization of chronic myeloid leukaemia patients at an oncologic centre: A retrospective observational study
Ana Maria Meireles; Rita Calisto; Maria José Bento; Pedro Martinho Gouveia; Susana Bizarro; Manuel Teixeira; Cláudia Moreira; Ana Espírito Santo; Mário Mariz;
Hematol Transfus Cell Ther. 2025;47:
Clinical and laboratorial characterization of a cohort of patients with hereditary platelet disorders in Brazil
Letícia Dalla Vecchia Grassi; Erica Okazaki; Cynthia Rothschild; Paula Villaça; Fernanda Andrade Orsi; Bianca Stefanello;
Hematol Transfus Cell Ther. 2025;47:
Benefits of BV-AVD (Brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine) versus ABVD (doxorubicin hydrochloride, bleomycin sulfate, vinblastine sulfate, dacarbazine) in patients with advanced-stage Hodgkin's lymphoma: an analysis of the ECHELON 1 trial by the GATLA group using the Delphi Method
Astrid Pavlovsky; Juan Ignacio Garcia Altuve; Amalia Cerutti; Lorena Fiad; Nicolás Kurgansky; Fernando Warley; Florencia Negri Aranguren;
Hematol Transfus Cell Ther. 2024;46 Supl 6:S250-6